Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Catherine Sampson has worked on the following 7 EPO patent applications which have been published in the last five years:

EP14719739

MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MEMBRANE ANTIGENS

IPC classification:
A61K 35/00, A61K 39/095, A61K 39/108, A61K 39/385, C07K 14/285
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
EXAMINATION REQUESTED
EP15192029

ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE

IPC classification:
A61K 39/00, A61K 39/095, G01N 30/02, G01N 33/53, G01N 33/548, G01N 33/569, G01N 33/66
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11736500

LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

IPC classification:
A61K 9/127, A61K 39/00, C12N 15/86
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
PATENT GRANTED
EP14799018

SALMONELLA CONJUGATE VACCINES

IPC classification:
A61K 47/48, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
EXAMINATION REQUESTED
EP14806633

PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS BY GLYCOPROTEIN VACCINES SYNTHESIZED IN ESCHERICHIA COLI

IPC classification:
A61K 39/085
Agent:
Catherine Sampson, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15711523

MUTANT STAPHYLOCOCCAL ANTIGENS

IPC classification:
A61K 39/00, A61K 39/085, A61K 39/39, C07K 14/31
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
EXAMINATION REQUESTED
EP17160320

PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES

IPC classification:
A61K 39/085, A61K 39/385
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Catherine Sampson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature